Literature DB >> 15054613

Histamine H(3) antagonists in models of obesity.

A A Hancock1, E N Bush, P B Jacobson, R Faghih, T A Esbenshade.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054613     DOI: 10.1007/s00011-003-0322-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  2 in total

1.  Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetes.

Authors:  Ashwin U Rao; Ning Shao; Robert G Aslanian; Tin-Yau Chan; Sylvia J Degrado; Li Wang; Brian McKittrick; Mary Senior; Robert E West; Shirley M Williams; Ren-Long Wu; Joyce Hwa; Bhuneshwari Patel; Shuqin Zheng; Christopher Sondey; Anandan Palani
Journal:  ACS Med Chem Lett       Date:  2011-11-21       Impact factor: 4.345

2.  Non-imidazole histamine H3 ligands: part V. synthesis and preliminary pharmacological investigation of 1-[2-thiazol-4-yl- and 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.

Authors:  Roman Guryn; Marek Staszewski; Krzysztof Walczyński
Journal:  Med Chem Res       Date:  2012-11-29       Impact factor: 1.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.